Agenus to Report Fourth Quarter and Year End 2012 Financial Results on February 28, 2013; Conference Call to Follow

Agenus Inc. (NASDAQ: AGEN) will release its fourth quarter and year ended December 31, 2012 financial results before the market opens on February 28, 2013.

Agenus executives will host a conference call at 11:00 a.m. Eastern Time that same day. To access the live call, dial 877.475.3568 (domestic) or 678.809.3092 (international); the access code is 14310694. The call will also be webcast and will be accessible from the company’s website at www.agenusbio.com/webcast/. A replay will be available approximately two hours after the call through midnight Eastern Time on April 25, 2013. The replay number is 855.859.2056 (domestic) or 404.537.3406 (international), and the access code is 14310694. The replay will also be available on the company’s website approximately two hours after the live call.

Agenus Inc. is a biotechnology company working to develop treatments for cancers and infectious diseases. The company is focused on immunotherapeutic products based on strong platform technologies with multiple product candidates advancing through the clinic, including several product candidates that have advanced into late-stage clinical trials through corporate partners. Between Agenus and its partners, 19 programs are in clinical development. For more information, please visit www.agenusbio.com.

Contact:

Media and Investor Contact:
Jonae R. Barnes
Vice President
Investor Relations and
Corporate Communications
jonae.barnes@agenusbio.com
617-818-2985


print email pdf rss